# Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

> **NCT06626022** · PHASE3 · RECRUITING · sponsor: **University of Alberta** · enrollment: 1284 (estimated)

## Conditions studied

- Prostate Cancer Screening

## Interventions

- **DEVICE:** MRI
- **DEVICE:** ExactVu

## Key facts

- **NCT ID:** NCT06626022
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2029-11-30
- **Final completion:** 2029-11-30
- **Target enrollment:** 1284 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626022, "Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06626022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*